MARVELD1 anticorps (N-Term)

N° du produit ABIN6991231

Cet anticorps Lapin Polyclonal détecte spécifiquement MARVELD1 dans WB et ELISA. Il présente une réactivité envers Humain, Souris et Rat.

Aperçu rapide pour MARVELD1 anticorps (N-Term) (ABIN6991231)

Antigène: MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MARVELD1 est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-MARVELD1 anticorps

Épitope: N-Term

Purification: MARVELD1 Antibody is affinity chromatography purified via peptide column.

Immunogène: MARVELD1 antibody was raised against a 16 amino acid synthetic peptide from near the amino terminus of human MARVELD1. The immunogen is located within the first 50 amino acids of MARVELD1.

Isotype: IgG

Information d'application

Indications d'application: MARVELD1 antibody can be used for detection of MARVELD1 by Western blot at 1 - 2 μ,g/mL.

Antibody validated: Western Blot in mouse samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: MARVELD1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: MARVELD1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur MARVELD1

Antigène: MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))

Autre désignation: MARVELD1

Sujet: MARVELD1 Antibody: MARVELD1, (MARVEL domain-containing 1), is one of the MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain-containing proteins. It is a nuclear-localized protein that is widely expressed in normal human tissues. While it has been reported to be overexpressed in colon cancer, MARVELD1 protein levels are generally lower in several primary tumors including ovary, breast, kidney, bladder and liver. This lower level of MARVELD1 expression in tumors is thought to be due to a higher methylation status of the MARVELD1 promoter as treatment of MDA-MB-361 with 5-aza-2'-deoxycytidine restores MARVELD1 expression, suggesting that loss of MARVELD1 expression may contribute to tumorgenicity.

ID gène: 83742

UniProt: Q9BSK0